CLN Stat
PermalinkRecommendFacebookEmailComments
A free AACC webinar on November 19 will examine how the first laboratory assay for assessing a critically ill patient’s risk of developing moderate to severe acute kidney injury (AKI) could change care paradigms. AKI is an under-recognized condition, affecting nearly 2 million patients annually in ...(Read More)
PermalinkRecommendFacebookEmailComments
AACC’s first-ever virtual conference, Personalized Diagnostics Today​, is quickly approaching on October 28-29, 2014, and one of the highlights will be “The Emerging Role of Pharmaco-epigenetics in High-Resolution Personalized Medicine” session, hosted by Mark W. Linder, PhD, of the University of L...(Read More)
PermalinkRecommendFacebookEmailComments
At AACC’s first-ever virtual conference, a panel of experts representing four distinct clinical settings will discuss how their institutions have introduced pharmacogenetic testing, as well as the lessons they have learned along the way. Each of the panelists’ organizations operate in different nic...(Read More)
PermalinkRecommendFacebookEmailComments
U.S. laboratories are on high alert as the Ebola outbreak in West Africa worsens. Now that the outbreak has spread to American shores with a patient currently being treated at Texas Health Presbyterian Hospital in Dallas, how should clinical labs at other institutions prepare to respond? An AACC-sp...(Read More)
1 - 4 Next